Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome

Sungyong You, Beatrice S. Knudsen, Nicholas Erho, +12

Cancer Research

Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease

Edmund C. Lee, Tania Valencia, Charles Allerson, +22

Nature Communications

High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program

David P. Labbé, Giorgia Zadra, Meng Yang, +31

Nature Communications

DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis

Jonathan F. Goodwin, Vishal Kothari, Justin M. Drake, +26

Cancer Cell

MedicineProstate Cancer ProgressionProstatic DiseaseCancer BiologyCell Biology +1

Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis

Benjamin Benzon, Shuang G. Zhao, Michael C. Haffner, +19

Prostate Cancer and Prostatic Diseases

Androgen ReceptorUrologyImmune PathwaysHormonal ReceptorImmunology +4

Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer

Lingjian Yang, Darren L. Roberts, Mandeep Takhar, +25

EBioMedicine

Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer

Alfonso Urbanucci, Stefan J. Barfeld, Ville Kytölä, +32

Cell Reports

Prostate cancer radiomics and the promise of radiogenomics

Radka Stoyanova, Mandeep Takhar, Yohann Tschudi, +8

Translational Cancer Research

Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

Roland Seiler, Ewan A. Gibb, Natalie Q. Wang, +20

Clinical Cancer Research

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies

Radka Stoyanova, Alan Pollack, Mandeep Takhar, +16

Oncotarget